Fior-Markets-Logo.jpg
Global Diphtheria, Pertussis, and Tetanus (DTaP) Vaccine Market is Expected to Reach USD 5.07 Billion by 2026 : Fior Markets
16 janv. 2020 21h00 HE | Fior Markets
New Jersey, NJ, Jan. 16, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global diphtheria, pertussis, and tetanus (DTaP) vaccine market is expected to grow from USD 2.97...
RND logo.PNG
Tetanus Toxoid Vaccine Market To Reach USD 6.46 Billion By 2026 | Reports And Data
15 avr. 2019 13h04 HE | Reports And Data
The rise in the number of reported cases of tetanus and diphtheria in the developing countries will be the major factor influencing the market growth. Market Size – USD 4.35 Billion in 2018, Market...
RND logo.PNG
DTaP Vaccine Market To Reach USD 5.00 Billion By 2026 | Reports And Data
15 avr. 2019 12h14 HE | Reports And Data
Growing demand for DTaP vaccines to prevent the occurrence of diseases such as diphtheria, tetanus, and pertussis is a significant factor expected to stimulate market growth. Market Size – USD 2.88...
logo long.jpg
Global Adult Vaccines Market to Surpass US$ 23.65 Billion by 2025
05 avr. 2018 10h00 HE | Coherent Market Insights
SEATTLE, April 05, 2018 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global adult vaccines market is estimated to be valued at US$ 12,806.4 million in 2017 and is projected to...